How is industry capacity trending, and what is the outlook for outsourcing? A recent study by BioPlan Associates reveals key ...

The Pharmaceutical Research and Manufacturers of America has filed a complaint that challenges the US government’s MFN drug ...

BD (Becton, Dickinson and Company), a medical technology company, has announced a partnership with the US government under which the company has agreed to invest $19 billion in the ...

AstraZeneca has announced the opening of a new $1-billion global strategic research and development (R&D) center, in Kendall Square, Cambridge, Massachusetts. The center is part of the company’s ...

How are small-molecules faring in 2026? To answer that question, DCAT Value Chain Insights examined where the small-molecules drugs among the 11 drugs identified by Clarivate, a business intelligence ...

The White House is moving to identify new and unused domestic, US-based, and near-shore production capacity to meet a goal of localizing manufacturing of essential medicines. The White House is moving ...

Roche’s Genentech has broken ground on a $750-million, 211,000-square-foot expansion of its manufacturing facility in Hillsboro, Oregon, to add device fill–finish capabilities, including the ...

AstraZeneca has agreed to take a $2-billion equity stake in Summit Therapeutics, a Miami-based bio/pharmaceutical company, and the companies have formed a clinical collaboration to evaluate Summit’s ...

Sanofi has expanded its antibody collaboration with Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical company, to add four new drug candidates in an $8-billion deal ($1 billion ...

Novo has entered into a license agreement with Hengrui Pharma, a Shanghai-based bio/pharmaceutical company, for HRS-1596, a Phase I-ready glucagon-like peptide-1 receptor (GLP-1R) and gastric ...